Skip to content
ChinaCSR.com logo

Corporate Social Responsibility & Sustainability in China

Corporate Social Responsibility in China

SFDA Investigates Fake Human Serum Albumin

June 12, 2007
-
Health

Following CCTV's report of fake human serum albumin being used on patients in Jilin Province, China's State Food and Drug Administration has begun to investigate the use of the fake substance across the country.

Yan Jiangying, a spokesperson from SFDA, has told local media that because the fake human albumin had been used in many provinces, the SFDA began a special investigation in March 2007 and it had already strengthened the management on blood products.

Human albumin is distilled from a healthy human body to help increase blood content, detoxification and nutritional supply. In recent years, the function of human albumin has been over-exaggerated which has resulted in an abuse of it. Also, as the supply falls short of demand, much fake human albumin has come out.

The SFDA has already identified a batch of counterfeit human albumin in Jilin, Shanxi, Hubei, Hunan, Ningxia, Qinghai and Chongqing and says it has taken effective measures to prevent these fake products from spreading into other regions. The relevant persons involved have reportedly already been arrested.

Readers also read this:

XCMG Machinery Releases ESG Report

August 14, 2024

Norwegian Agri CEO Makes Green Visit To China

June 1, 2024

Sino-French Dairy Cooperation Takes Flight

May 15, 2024

China Construction Bank Signs ESG Platform Deal In Singapore

April 30, 2024

Inaugural One Earth Summit Concludes In Hong Kong

March 28, 2024

United Nations Global Compact Welcomes Latest Chinese Company

February 8, 2024
  • About Us
  • Contact Us
  • Corrections and Disclosure Policy
  • Privacy Policy
  • Terms & Conditions
  • 中文
Menu
  • About Us
  • Contact Us
  • Corrections and Disclosure Policy
  • Privacy Policy
  • Terms & Conditions
  • 中文

Copyright 2026 © ChinaCSR.com. All Rights Reserved. A service of Asia Media Network. If you would like to syndicate these articles and posts, please utilize the RSS feed for this online publication, which provides a brief summary of each post with a link back to the original article. Posting of any other part of the articles or posts on this website for commercial purposes created by ChinaCSR.com, in whole or in part, is expressly prohibited without express written permission from ChinaCSR.com. Individual news stories curated from other sources are copyright their respective sources.

Asia Media Network